porcin
epidem
diarrhea
viru
pedv
caus
high
mortal
neonat
piglet
howev
effect
safe
vaccin
still
avail
hypothes
inactiv
activ
endocytosi
signal
spike
protein
attenu
pedv
yet
retain
immunogen
pig
gener
recombin
pedv
kdke
quadrupl
alanin
substitut
catalyt
tetrad
use
virul
infecti
cdna
clone
backbon
next
construct
anoth
mutant
kdke
sya
abolish
endocytosi
signal
spike
protein
kdke
compar
kdke
kdke
sya
mutant
replic
less
effici
vitro
induc
stronger
type
type
iii
interferon
respons
pathogenesi
immunogen
mutant
evalu
gnotobiot
piglet
virul
kdke
sya
kdke
significantli
reduc
compar
mortal
rate
kdke
kdke
syainocul
group
respect
day
postinocul
dpi
surviv
pig
challeng
oral
high
dose
kdke
syaand
kdke
inocul
pig
protect
challeng
kdke
syaand
one
kdke
inocul
pig
develop
diarrhea
wherea
pig
mockinocul
group
sever
diarrhea
die
furthermor
serial
passag
kdke
sya
mutant
pig
three
time
find
revers
introduc
mutat
data
suggest
kdke
sya
may
pedv
vaccin
candid
import
pedv
econom
import
porcin
enter
viral
pathogen
caus
immens
econom
loss
pork
industri
mani
countri
effect
safe
vaccin
desper
requir
still
avail
highli
conserv
among
coronavirus
cov
inactiv
live
attenu
vaccin
attempt
sever
betacoronavirus
show
inactiv
endocytosi
signal
spike
protein
approach
design
promis
live
attenu
vaccin
pedv
vivo
passag
data
also
valid
stabil
kdke
sya
mutant
kdke
sya
warrant
evalu
sow
piglet
may
use
platform
optim
find
confirm
univers
target
cov
vaccin
develop
aid
develop
vaccin
emerg
cov
within
famili
coronavirida
genom
rna
grna
contain
six
known
open
read
frame
encod
replicas
polyprotein
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
accessori
protein
glycoprotein
mediat
receptor
bind
membran
fusion
viru
entri
harbor
major
viral
neutral
epitop
pedv
classic
strain
genogroup
emerg
unit
kingdom
caus
endem
outbreak
mani
european
asian
countri
highli
virul
pedv
strain
emerg
china
virus
sinc
spread
north
america
europ
asian
countri
caus
epidem
outbreak
result
massiv
mortal
neonat
piglet
pedv
first
detect
us
swine
caus
death
million
pig
within
year
lead
billion
econom
loss
prevent
control
deadli
diseas
us
depart
agricultur
condit
licens
two
pedv
vaccin
one
viral
vectorbas
subunit
vaccin
harrisvaccin
inc
acquir
merck
co
inactiv
vaccin
zoeti
inc
nevertheless
efficaci
vaccin
remain
question
togeth
knowledg
vaccin
swine
enter
virus
rotaviru
transmiss
gastroenter
viru
tgev
oral
immun
sow
live
attenu
vaccin
lav
promis
approach
protect
newborn
piglet
highli
virul
pedv
pedv
lav
base
classic
strain
appli
asian
countri
efficaci
emerg
highli
virul
strain
minim
probabl
due
antigen
differ
protein
strain
develop
pedv
lav
research
group
previous
appli
tradit
method
attenu
via
serial
passag
virul
isol
vero
cell
although
lav
candid
attenu
suffici
pig
usual
fail
consist
induc
adequ
protect
immun
challeng
virul
strain
one
potenti
reason
multipl
mutat
accumul
gene
vero
celladapt
pedv
mutat
may
alter
antigen
protein
impair
viral
immunogen
vivo
lead
decreas
efficaci
therefor
better
strategi
pedv
lav
maintain
critic
epitop
protein
conserv
wildtyp
virus
retain
optim
immunogen
major
concern
lav
safeti
issu
caus
point
mutat
recombin
field
therefor
pedv
lav
harbor
ration
introduc
mutat
multipl
locat
viral
genom
reduc
potenti
revers
virul
vaccin
candid
gener
use
infecti
cdna
clone
virul
pedv
strain
similar
coronavirus
cov
pedv
replicas
polyprotein
process
nonstructur
protein
nsp
respons
viral
replic
transcript
translat
etc
end
viral
genom
rna
subgenom
mrna
sgmrna
contain
cap
structur
methyl
guanosin
nucleosid
cap
methyl
group
posit
cap
first
nucleotid
cap
structur
critic
effect
translat
viral
protein
evas
host
innat
immun
methyl
two
site
cap
catalyz
three
nsp
methyltransferas
mtase
domain
cov
contain
catalyt
tetrad
amino
acid
residu
k
k
e
directli
respons
enzymat
activ
inactiv
demonstr
effect
approach
ration
design
lav
candid
cov
sinc
viral
protein
highli
conserv
among
cov
recombin
virus
carri
mutat
usual
viabl
document
introduct
substitut
sever
acut
respiratori
syndrom
cov
sarscov
middl
east
respiratori
syndrom
cov
merscov
equival
substitut
mous
hepat
viru
mhv
attenu
cov
mice
subsequ
studi
also
demonstr
inactiv
exonucleas
domain
attenu
sarscov
mice
increas
genet
stabil
moreov
primari
infect
recombin
sarscov
fulli
protect
mice
lethal
challeng
virul
viru
suggest
cov
abolish
could
univers
lav
platform
addit
mutat
studi
appli
knowledg
pedv
gener
evalu
lav
platform
use
virul
pedv
infecti
cdna
clone
backbon
pedv
mutant
inactiv
gener
partial
complet
kdke
replac
catalyt
tetrad
achiev
higher
level
attenu
reduc
potenti
revers
inactiv
endocytosi
signal
cytoplasm
tail
protein
kdke
gener
kdke
sya
demonstr
previous
inactiv
endocytosi
signal
partial
attenu
virul
neonat
piglet
without
alter
major
neutral
epitop
lack
signal
also
caus
protein
transport
cell
surfac
potenti
lead
improv
recognit
pedv
mutant
host
immun
system
present
studi
evalu
virul
immunogen
genet
stabil
kdke
kdke
sya
mutant
neonat
gnotobiot
gn
pig
also
character
abil
trigger
interferon
ifn
respons
vitro
gener
pedv
mutant
structur
biochem
studi
sarscov
reveal
replac
residu
catalyt
tetrad
k
k
e
alanin
significantli
inactiv
activ
first
model
structur
pedv
found
put
catalyt
tetrad
k
k
e
highli
homolog
counterpart
sarscov
fig
c
next
introduc
singl
alanin
substitut
quadrupl
alanin
substitut
design
kdke
mutant
catalyt
tetrad
gener
two
recombin
pedv
mutant
fig
final
third
mutant
kdke
sya
construct
inactiv
kdke
endocytosi
signal
protein
fig
three
mutant
kdke
kdke
sya
rescu
vero
cell
supernat
contain
rescu
virus
harvest
passag
singl
clone
mutant
purifi
plaqu
assay
complet
genom
sequenc
pedv
mutant
verifi
sanger
sequenc
inactiv
decreas
viral
replic
antagon
pretreat
vero
cell
character
phenotyp
recombin
pedv
vero
cell
growth
curv
fig
b
mutant
replic
similarli
virul
includ
similar
peak
infecti
titer
fig
mutant
also
form
plaqu
similar
size
fig
contrast
kdke
kdke
sya
replic
significantli
lower
peak
titer
p
demonstr
previous
sya
mutat
gene
enhanc
abil
mutant
icya
induc
cellcel
fusion
produc
larg
plaqu
thu
kdke
sya
mutant
produc
larger
plaqu
replic
effici
earli
time
point
kdke
mutant
also
document
sarscov
merscov
mutant
sensit
respons
cell
cultur
wildtyp
virus
compar
replic
recombin
pedv
vero
cell
pretreat
differ
concentr
fig
pretreat
inhibit
replic
dosedepend
manner
although
mutant
produc
significantli
lower
titer
progeni
virus
virul
kdke
kdke
sya
mutant
sensit
higher
concentr
mutant
sinc
mutat
locat
transcript
regulatori
sequenc
tr
fig
subgenom
level
icyaand
kdke
syainfect
vero
cell
one
log
unit
lower
cell
fig
kdke
kdke
sya
mutant
induc
stronger
ifn
respons
vitro
recent
studi
highlight
fact
type
iii
ifn
includ
play
signific
role
inhibit
pedv
infect
vitro
also
report
mhv
mutant
induc
stronger
product
wildtyp
viru
murin
macrophag
evalu
whether
pedv
mutant
trigger
enhanc
type
type
iii
ifn
respons
infect
cell
infect
swine
intestin
epitheli
cell
line
ipecdq
uvinactiv
pedv
mutant
multipl
infect
moi
cell
mock
treat
transfect
poli
neg
posit
control
growth
curv
analysi
show
kdke
kdke
sya
mutant
replic
significantli
lower
titer
virus
h
postinocul
hpi
fig
quantifi
mrna
swine
infect
cell
fig
f
compar
virul
kdke
kdke
sya
icya
mutant
induc
significantli
higher
mrna
level
ifn
hpi
uvinactiv
stimul
ifn
respons
next
perform
luciferas
assay
examin
whether
infect
mutant
pedv
activ
promot
hpi
fig
h
ifn
promot
activ
mocktreat
cell
howev
kdke
kdke
sya
mutant
activ
promot
induc
significantli
stronger
luciferas
activ
ipecdq
cell
p
collect
data
suggest
pedv
kdke
kdke
sya
mutant
trigger
stronger
type
type
iii
ifn
product
infect
cell
virul
pedv
kdke
kdke
sya
mutant
attenu
differ
extent
neonat
piglet
compar
singl
mutant
kdke
kdke
amino
acid
sequenc
motif
yevf
red
motif
kvhvq
blue
mutat
amino
acid
nucleotid
bold
stop
codon
protein
indic
dot
predict
tr
underlin
sya
mutant
replic
less
effect
sensit
respons
vitro
investig
pathogenesi
immunogen
neonat
gn
piglet
first
day
postinocul
dpi
clinic
sign
mortal
observ
pig
mockinocul
group
tabl
eight
piglet
sever
diarrhea
die
within
dpi
kdke
inocul
piglet
sever
diarrhea
one
piglet
die
dpi
comparison
one
kdke
syainocul
piglet
sever
diarrhea
day
pig
die
fig
kdke
kdke
syainfect
piglet
significantli
lower
delay
peak
infecti
pedv
shed
titer
pig
versu
pfuml
p
tabl
signific
differ
observ
amount
infecti
pedv
rectal
swab
fig
intestin
content
fig
kdke
keke
syainocul
pig
time
point
level
sera
collect
two
pig
euthan
dpi
differ
significantli
among
three
group
fig
pedv
n
protein
visual
epitheli
cell
jejunum
ileum
pedvinocul
piglet
use
immunohistochemistri
ihc
stain
fig
sever
villou
atrophi
infect
pig
quantifi
measur
ratio
villu
height
crypt
depth
vhcd
ratio
villu
two
mutant
induc
significantli
milder
villou
atrophi
jejunum
ileum
kdke
sya
mutant
induc
significantli
milder
villou
atrophi
ileum
kdke
mutant
fig
p
collect
data
suggest
inactiv
catalyt
tetrad
kdke
protein
significantli
attenu
highli
virul
pedv
neonat
piglet
addit
inactiv
endocytosi
signal
protein
reduc
virul
kdke
kdke
sya
mutant
induc
protect
virul
challeng
pig
dpi
surviv
pig
challeng
highli
virul
high
dose
pfupig
tabl
mortal
observ
kdke
kdke
syainocul
group
wherea
two
mockchalleng
pig
die
day
postchalleng
dpc
fig
dpc
kdke
syainocul
pig
diarrhea
one
kdke
inocul
pig
mild
diarrhea
day
howev
mockchalleng
pig
develop
sever
diarrhea
day
tabl
fig
infecti
pedv
detect
rectal
swab
sampl
pig
kdke
syainocul
group
one
sampl
one
pig
kdke
inocul
group
pedv
posit
day
low
infecti
titer
log
pfuml
howev
mockchalleng
pig
shed
high
titer
infecti
pedv
fece
dpc
fig
fecal
pedv
rnashed
profil
trend
rna
shed
kdke
kdke
sya
group
chang
significantli
contrast
mockchalleng
pig
shed
significantli
higher
titer
infecti
pedv
dpc
viral
rna
dpc
kdke
kdke
sya
group
p
also
determin
viral
neutral
vn
antibodi
titer
sera
collect
dpc
dpc
dpc
fig
primari
infect
two
pedv
mutant
piglet
elicit
vn
antibodi
challeng
challeng
significantli
boost
titer
dpc
significantli
higher
mockchalleng
pig
p
summari
infect
kdke
kdke
sya
piglet
induc
protect
respect
diarrhea
follow
subsequ
challeng
virul
introduc
mutat
kdke
sya
mutant
stabl
passag
three
time
pig
revers
virul
lav
repres
safeti
concern
use
livestock
kdke
sya
mutant
harbor
nucleotid
substitut
genom
induc
protect
neonat
pig
evalu
genet
stabil
introduc
mutat
serial
passag
viru
pig
three
time
fig
viral
genom
intestin
content
third
passag
verifi
sanger
sequenc
sequenc
alter
found
nine
introduc
mutat
fig
viru
acquir
one
synonym
mutat
two
synonym
mutat
one
nonsynonym
mutat
subunit
fig
sequenc
cytoplasm
tail
region
rectal
swab
sampl
kdke
infect
n
kdke
syainfect
n
pig
collect
dpi
find
revers
introduc
mutat
data
shown
due
low
pedv
rna
titer
rang
log
n
gene
copiesml
rectal
swab
sampl
abl
amplifi
suffici
amount
complet
genom
sequenc
mutant
collect
data
indic
introduc
mutat
catalyt
tetrad
pedv
cytoplasm
tail
region
stabl
vivo
emerg
reemerg
enter
cov
swine
includ
pedv
porcin
deltacoronaviru
pdcov
swine
acut
diarrhea
syndrom
sad
cov
rais
concern
econom
impact
global
pork
industri
cov
caus
clinic
similar
gastroenter
induc
crossneutr
pig
necessari
develop
effect
safe
lav
individu
cov
protein
cov
highli
conserv
among
cov
repres
suitabl
mutagenesi
target
purpos
current
studi
use
pedv
exampl
valid
concept
evalu
virul
recombin
pedv
bear
inactiv
viral
newborn
gn
pig
character
protect
efficaci
pig
challeng
highli
virul
pedv
combin
inactiv
activ
endocytosi
signal
protein
show
kdke
sya
mutant
attenu
induc
better
protect
kdke
virulentpedv
challeng
also
confirm
introduc
mutat
kdke
sya
genom
stabl
passag
mutant
viru
gn
pig
three
time
current
pedv
strain
circul
among
pig
differ
countri
two
subtyp
pedv
cocircul
unit
state
highli
virul
origin
us
pedv
strain
eg
clinic
milder
sindel
pedv
strain
eg
previou
studi
demonstr
live
sindel
strain
induc
partial
crossprotect
challeng
origin
us
pedv
although
two
subtyp
pedv
induc
similar
level
vn
antibodi
serum
vn
antibodi
crossreact
sera
collect
studi
also
crossneutr
sindel
strain
level
vero
cell
data
shown
pig
experi
need
examin
whether
origin
us
pedvbas
kdke
sya
mutant
induc
suffici
protect
challeng
heterolo
gou
sindel
pedv
strain
howev
origin
us
pedv
strain
main
target
pedv
lav
due
high
virul
preval
field
catalyt
tetrad
kdke
highli
conserv
coronavirida
also
viral
famili
show
consist
attenu
phenotyp
similarli
engin
cov
flavivirus
paramyxoviru
pedv
mutant
without
activ
attenu
neonat
gn
piglet
becam
vulner
innat
immun
respons
fig
kdke
mutant
harbor
four
alanin
substitut
catalyt
tetrad
differ
previous
report
mhv
sarscov
merscov
contain
one
amino
acid
mutat
shown
replac
residu
alanin
almost
complet
abolish
activ
escherichia
coliexpress
sarscov
vitro
studi
demonstr
first
time
cov
lack
kdke
residu
still
viabl
vitro
vivo
design
also
improv
safeti
pedv
lav
candid
activ
restor
four
alanin
substitut
revert
kdke
pedv
mutant
evalu
pig
specul
singl
mutant
might
virul
kdke
mutant
similar
observ
mutant
sarscov
merscov
unlik
sarscov
merscov
mutant
replic
equival
wild
type
kdke
mutant
replic
lower
titer
fig
b
gener
smaller
plaqu
fig
parent
viru
vero
cell
one
potenti
reason
kdke
residu
may
unknown
function
viral
replic
also
possibl
pedv
mutant
may
still
retain
margin
activ
wherea
kdke
mutant
may
complet
lost
enzymat
activ
substanti
evid
support
point
obtain
quantif
percentag
viral
rna
mutant
use
radioactivelabel
approach
less
effici
replic
kdke
kdke
sya
vero
cell
may
drawback
largescal
product
pedv
lav
issu
overcom
use
engin
cell
line
support
effect
replic
mutant
report
replic
mhv
mutant
also
poor
wildtyp
macrophag
enhanc
addit
mutat
mark
red
rdrp
rnadepend
rna
polymeras
endou
endoribonucleas
subunit
protein
interferoninduc
protein
tetratricopeptid
repeat
ifit
knockout
macrophag
altern
stabl
express
wildtyp
cell
line
may
compens
inactiv
catalyt
tetrad
function
mutant
restor
viru
propag
vitro
although
cell
line
may
facilit
revers
mutant
vitro
similar
infect
enter
rna
virus
pedv
infect
elicit
type
type
iii
ifn
trigger
innat
immun
respons
pig
secret
variou
immun
epitheli
cell
known
induc
antivir
effect
system
act
clear
enter
viral
pathogen
restrict
replic
epitheli
cell
contrast
mainli
produc
epitheli
cell
activ
antivir
respons
mucos
site
howev
sever
studi
report
pedvinfect
epitheli
cell
line
express
significantli
increas
amount
type
type
iii
ifn
earli
stage
infect
usual
within
h
probabl
due
inhibit
multipl
viral
protein
far
determin
least
pedv
protein
suppress
ifn
product
includ
e
n
instanc
inactiv
endoribonucleas
pedv
reduc
ifn
antagon
result
enhanc
induct
type
type
iii
ifn
vitro
viral
attenu
vivo
present
studi
also
observ
similar
result
pedv
mutant
inactiv
mutant
trigger
earlier
ifn
respons
ipecdq
cell
probabl
due
viral
rna
trigger
sensor
molecul
melanoma
differentiationassoci
protein
inocul
kdke
kdke
sya
induc
higher
level
sera
pig
euthan
dpi
fig
like
due
much
robust
replic
virul
two
mutant
vivo
could
determin
local
ifn
respons
intestin
tissu
due
pig
euthan
earli
time
point
eg
within
hpi
base
studi
vero
celladapt
pedv
lav
level
host
immun
respons
correl
effici
viral
replic
intestin
tendenc
induc
stronger
local
ifn
respons
earli
stage
infect
pedv
mutant
may
contribut
overal
immunogen
although
virus
replic
less
robustli
vivo
investig
infect
pedv
mutant
pig
porcin
enteroid
cultur
may
discov
detail
mechan
compar
kdke
kdke
sya
doubl
mutant
display
higher
level
attenu
piglet
induc
better
protect
diarrhea
postchalleng
high
dose
highli
virul
pedv
doubl
mutant
may
induc
improv
immun
respons
pig
potenti
due
combin
effect
kdke
icya
mutant
mutat
cytoplasm
tail
protein
inactiv
endocytosi
signal
yevf
also
disrupt
tr
sgmrna
nucleotid
fig
result
decreas
synthesi
infect
cell
sinc
pedv
protein
ifn
antagonist
icya
mutant
also
induc
higher
type
type
iii
ifn
respons
ipecdq
cell
fig
moreov
inactiv
endocytosi
signal
enhanc
format
syncytia
may
facilit
spread
kdke
sya
mutant
cell
earli
stage
infect
observ
kdke
sya
mutant
replic
slightli
higher
titer
kdke
mutant
dpi
piglet
tabl
fig
lack
endocytosi
signal
increas
amount
protein
present
surfac
infect
enterocyt
contribut
better
cell
activ
futur
studi
cellular
immun
respons
mutant
pig
warrant
increas
understand
mechan
enhanc
attenu
better
immun
kdke
sya
kdke
maintain
genet
stabil
cov
lav
candid
critic
vaccin
develop
recombin
cov
mutat
certain
viral
protein
unstabl
vivo
exampl
serial
passag
balbc
mice
day
time
recombin
sarscov
lack
entir
e
protein
acquir
addit
pdzbind
motif
pbm
accessori
protein
compens
loss
motif
e
protein
contrast
catalyt
tetrad
cov
seem
stabl
target
mutagenesi
sarscov
mutant
retain
two
nucleotid
substitut
continu
replic
immunedefici
mice
day
similarli
also
show
nine
nucleotid
substitut
stabl
vivopassag
kdke
sya
fig
fecal
sampl
collect
dpi
kdke
kdke
syainfect
pig
three
passag
pig
total
day
genom
kdke
sya
mutant
acquir
one
addit
amino
acid
substitut
subunit
three
synonym
mutat
fig
howev
unlik
mutat
protein
compens
miss
activ
pedv
mutant
would
interest
evalu
pathogenesi
vivopassag
viru
pig
futur
notabl
compar
young
pig
older
anim
matur
immun
system
induc
stronger
select
pressur
introduc
mutat
also
necessari
evalu
genet
stabil
kdke
sya
adult
pig
futur
anoth
approach
prevent
potenti
revers
virul
cov
introduc
mutat
multipl
gene
differ
function
certain
select
pressur
vivo
mutat
one
gene
may
revert
wild
type
addit
mutat
may
still
preserv
retain
attenu
also
two
independ
recombin
event
requir
revert
two
distant
mutat
wild
type
lav
virul
viru
coinfect
cell
one
studi
show
combin
inactiv
reduc
revers
virul
recombin
sarscov
vivo
similar
effect
also
observ
recombin
sarscov
combin
delet
e
protein
studi
combin
mutat
made
kdke
endocytosi
signal
interestingli
remov
endocytosi
signal
occur
natur
gene
vero
celladapt
field
pedv
strain
suggest
stabl
pedv
replic
vivo
vitro
collect
data
suggest
engin
kdke
sya
mutant
genet
stabl
pig
vaccin
regimen
includ
vaccin
dose
boost
use
adjuv
time
determin
efficaci
pedv
lav
pedvnaiv
pig
neonat
piglet
appropri
target
pedv
vaccin
due
rapid
diseas
develop
death
first
week
life
protect
acquir
pedvneutr
antibodi
via
colostrum
milk
sow
thu
stimul
suffici
lactogen
immun
respons
sow
key
pedv
vaccin
studi
inocul
piglet
pfupig
virul
equival
median
diarrhea
dose
pdd
mutant
dose
oral
immun
sow
may
like
need
increas
due
agerel
decreas
suscept
potenti
preexist
pedv
antibodi
older
anim
immunogen
kdke
andor
kdke
sya
mutant
pregnant
sow
also
need
evalu
futur
recent
studi
demonstr
intramuscular
inocul
virul
pedv
trigger
intestin
infect
pig
suggest
oral
vaccin
may
combin
rout
establish
better
primari
infect
intestin
sow
use
pedv
booster
vaccin
adapt
previou
tgev
rotaviru
studi
administr
subunit
inactiv
vaccin
booster
improv
efficaci
oral
lav
vitamin
probiot
demonstr
effect
adjuv
rotaviru
vaccin
pig
moreov
time
vaccin
significantli
affect
multipl
immun
paramet
sow
recent
studi
show
pedv
infect
second
trimest
gestat
stimul
strongest
protect
immun
respons
gilt
compar
gilt
inocul
first
third
trimest
conclus
develop
evalu
pedv
lav
candid
combin
inactiv
abolish
endocytosi
signal
protein
mutant
pedv
replic
less
effect
induc
stronger
type
type
iii
ifn
respons
cell
cultur
data
illustr
strategi
safe
effect
